PROVIDENCE Spending on GLP-1s, the pricey drugs used to treat diabetes and obesity, including Ozempic and Wegovy, nearly tripled in Rhode Island between 2021 and 2023, amid the rapid uptake in the popular medications, a new state report found
With millions more people struggling with obesity than diabetes, the financial incentive to market GLP-1s as a weight-loss solution is undeniable
If using DSIP specifically, the deep-sleep enhancement effects are usually apparent by this point
Scenario 1: Using 1mL of BAC Water This is a very common and straightforward choice
Acta Physiol (Oxf) 2012;204:277287
For 18 months (typical to reach full response), thats $20,000-$24,000 out of pocket without insurance